American Journal of Medicine and Medical Sciences
p-ISSN: 2165-901X e-ISSN: 2165-9036
2021; 11(6): 471-475
doi:10.5923/j.ajmms.20211106.03
Received: Apr. 19, 2021; Accepted: May 26, 2021; Published: Jun. 15, 2021
Khudaiberdiev Kh. I., Khakimov Z. Z., Rakhmanov A. Kh.
Pharmacology Department, Tashkent Medical Academy, Tashkent, Uzbekistan
Correspondence to: Khudaiberdiev Kh. I., Pharmacology Department, Tashkent Medical Academy, Tashkent, Uzbekistan.
Email: | ![]() |
Copyright © 2021 The Author(s). Published by Scientific & Academic Publishing.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
The effectiveness of the medicine- Convaren for restoration of bile-forming function of liver was studied in comparison with Celagrip, Lesbokhol, Liv.52, and Silibor on tetracycline induced acute hepatitis model. Experimental studies were conducted on white male rats with an initial body weight of 170-200 g. The drug lesion was reproduced by daily oral administration of tetracycline at a dose of 500 mg/kg into the stomach using a metal probe for 5 days. The animals were treated with Celagrip (25 mg/kg), Lesbokhol (25 mg/kg), Convaren (50 mg/kg), Liv.52 (100 mg/kg), and Silibor (80 mg/kg) for 6 days. Under the influence of Convaren, the excretion of bile increased by 48,2%, bile acids excretion increased by 89,6%, cholesterol by 94,8%, and bilirubin by 32,6% in tetracycline-induced hepatitis. Convaren showed a more significant impact on the improvement of the bile-secretion activity of the liver in drug-induced hepatitis compared with Silibor, Liv.52, Celagrip and Lesbokhol.
Keywords: Drug-induced hepatitis, Hepatoprotective activity, Bile formation, Lipid peroxidation, Antioxidants
Cite this paper: Khudaiberdiev Kh. I., Khakimov Z. Z., Rakhmanov A. Kh., Evaluation of the Pharmacological and Therapeutic Effects of Drugs of Natural Origin in the Management of Biliary Insufficiency in Tetracycline Induced Hepatitis, American Journal of Medicine and Medical Sciences, Vol. 11 No. 6, 2021, pp. 471-475. doi: 10.5923/j.ajmms.20211106.03.
[1] | Revyakin A. O., Kapanadze G. D., Kasinskaya N. V., Stepanova O. I., Baranova O. V., Kiselev A. G., 2014, Modeling of drug-induced toxic hepatitis in rats, Biomedicine, 1, p.52-53. |
[2] | Popov S. S., Shulgin K. K., Pashkov A. N., Zolotoyedov V. I., Shvedov G. I. 2012, The effect of combined treatment with melaxen on the intensity of lipid peroxidation and citrate concentration in the blood of patients with drug-Induced hepatitis, Experimental and clinical pharmacology, 75 (7), p.32-35. |
[3] | Ivashkin V. T., Baranovsky A. Yu., Raikhelson K. L., Palgova L. K., Mayevskaya M. V., Kondrashina E. A., Marchenko N. V., Nekrasova T. P., Nikitin I. G., 2019, Drug – Induced liver injuries (clinical recommendations for phisicians), Russian journal of gastroenterology, Hepatology, Coloproctology, 29 (1), p. 101-131. |
[4] | Bunyatyan N. D., Kalko E. A., Drogovoz S. M., Kononenko A.V., 2018 Chronopharmacological features of the action of hepatoprotectors in the experiment, Bulletin of experimental biology and medicine, 165, p. 712-715. |
[5] | Sukhanov D. S., Vinogradova T. I., Zabolotnykh N. V., Kovalenko A. L., Vasilyeva S. N., Romantsov M. G., 2011, Сomparative study of the hepatoprotective effect of remaxol, reamberin and ademetionin in liver damage with anti-tuberculosis drugs (experimental study), Antibiotics and chemotherapy, 56, p. 12-16. |
[6] | Skakun N. P., Vysotsky I. Yu., 1982, The effect of tetracycline antibiotics on lipid peroxidation, Antibiotics, 9, p. 44-46. |
[7] | Mironov A. N., Merkulov V. A. and others. Guidelines for conducting clinical trials of medicinal products (Immunobiological medicinal products). Part II, p. 178-187. |
[8] | Khakimov Z. Z., Z. T. Fayzieva, Mahmoudov S. S., 2017, The effect of Celagrip – an interferon inducer on the hepatobiliary system. Monography. Toshkent. |
[9] | Khakimov Z. Z., Mavlyanov Sh. R., Rakhmanov A. Kh., 2017, The effect of lesbochol on the content of glycogen in the liver in its acute toxic damage, Infection, immunity and pharmacology, 1, p. 129-134. |
[10] | Ya.Z. Akramova, I.V. Tsoi, D.Z. Khakimova, Z.Z. Khakimov, 2010, Effect of Convaren on metabolic processes and intensity of lipid peroxidation processes in drug-Induced liver damage, Pharmaceutical Bulletin of Uzbekistan, 1. p. 54-58. |
[11] | Andreeva A. I., Kozhemyakin L. A., 1988, Modification of the method for determining lipid peroxides in the test with thiobarbituric acid, Laboratory work, 11, p. 43-45. |
[12] | Gavrilov B. V., Mishkorudnaya M. M., 1983, Spectrophotometric determination of lipid hydroperoxides in blood plasma, Laboratory work,, 3, p. 47-51. |
[13] | Mavlanov Sh. R., Khakimov Z. Z., Rakhmonov A. Kh., 2017, Methods of experimental study of the effect of new pharmacologically active compounds on the functioning of the hepatobiliary system, Guidance manual, Tashkent. |
[14] | Khakimov Z. Z., Mavlyanov, S. R., Hojimatov O. K., 2014, The effect of lesbochol on the biliary function of the liver in its acute lesion, Medical journal of Uzbekistan, 1, p. 105-105. |
[15] | Khakimov Z. Z., Rakhmanov A. Kh., Ziyaeva Yu. V., 2019, Antihypoxic and actoprotective activity of lesbohol, Journal of theoretical and clinical medicine, 1, p. 12-15. |
[16] | Vanchikova A. G., Azhunova T. A., Naidanova E. G., 2013, Pharmacotherapeutic effectiveness of a complex herbal remedy for experimental hepatitis, Forms and methods of social work in various spheres of life, p. 77-79. |
[17] | Okovity S. V., Arkadiev V. A., Bezborotkina M. N., et al., 2007, New pleiotropic effect of simvastatin in experimental steatohepatitis in rats, Experimental and clinical pharmacology, 70(3), p. 43-45. |
[18] | Arushanyan, E. B., 2018, Melatonin and the activity of the liver, Experimental and clinical pharmacology, 81, 11, p. 32-37. |